- Home
- FLGT vs BXC Comparison
FLGT vs BXC Comparison
Compare FLGT & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- BXC
- Stock Information
- Founded
- FLGT 2011
- BXC 2004
- Country
- FLGT United States
- BXC United States
- Employees
- FLGT N/A
- BXC N/A
- Industry
- FLGT Medical Specialities
- BXC Wholesale Distributors
- Sector
- FLGT Health Care
- BXC Consumer Discretionary
- Exchange
- FLGT Nasdaq
- BXC Nasdaq
- Market Cap
- FLGT 588.5M
- BXC 551.4M
- IPO Year
- FLGT 2016
- BXC 2004
- Fundamental
- Price
- FLGT $19.37
- BXC $86.47
- Analyst Decision
- FLGT Buy
- BXC Strong Buy
- Analyst Count
- FLGT 2
- BXC 5
- Target Price
- FLGT $24.00
- BXC $115.40
- AVG Volume (30 Days)
- FLGT 206.2K
- BXC 118.4K
- Earning Date
- FLGT 08-01-2025
- BXC 07-29-2025
- Dividend Yield
- FLGT N/A
- BXC N/A
- EPS Growth
- FLGT N/A
- BXC N/A
- EPS
- FLGT N/A
- BXC 4.53
- Revenue
- FLGT $292,448,000.00
- BXC $2,935,514,000.00
- Revenue This Year
- FLGT $11.79
- BXC $3.40
- Revenue Next Year
- FLGT $10.45
- BXC $5.01
- P/E Ratio
- FLGT N/A
- BXC $18.92
- Revenue Growth
- FLGT 1.71
- BXC N/A
- 52 Week Low
- FLGT $14.57
- BXC $63.14
- 52 Week High
- FLGT $25.11
- BXC $134.79
- Technical
- Relative Strength Index (RSI)
- FLGT 41.40
- BXC 68.81
- Support Level
- FLGT $19.18
- BXC $80.42
- Resistance Level
- FLGT $19.96
- BXC $88.30
- Average True Range (ATR)
- FLGT 0.50
- BXC 3.48
- MACD
- FLGT -0.07
- BXC 1.13
- Stochastic Oscillator
- FLGT 26.29
- BXC 87.20
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.